Each tablet contains etoricoxib 60 mg/90 mg/120 mg Tablets.
Indicated in conditions associated with Pain and Inflammation, in conditions like Ankylosing spondylitis, Osteoarthritis, Rheumatoid arthritis.
Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2). This reduces prostaglandins (PGs) generation from arachidonic acid.
One tablet once a day
Hypersensitivity to the active substance(s) or to any of the excipients, Pregnancy and lactation. Patients with active peptic ulceration or active gastro-intestinal (GI) bleeding.
Caution is advised with treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly or patients with a prior history of gastrointestinal disease, such as ulceration and GI bleeding. Selective COX-2 inhibitor class of drugs may be associated with a risk of thrombotic events (especially myocardial infarction (MI) and stroke).
Etoricoxibis contraindicated in pregnancy. Women who use etoricoxib must not breast feed.Etoricoxib is contra-indicated in children and adolescents under 16 years of age
Concurrent use of etoricoxib and warfarin may result in increased prothrombin time, International Normalized Ratio (INR). Concurrent use of etoricoxib and rifampicin may result in decreased plasma concentration of etoricoxib.
The most common adverse effects are abdominal pain, Constipation, flatulence, gastritis, heartburn/acid reflux, diarrhea, dyspepsia/epigastric discomfort, nausea, vomiting, oesophagitis, oral ulcer